IMMUNE BIOTECH
ImmuneBiotech discovers and develops novel probiotics for therapeutic effect based on lactic acid bacteria and symbiotic formulations targeting gut microbiota and the immune system.
IMMUNE BIOTECH
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2013-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.immunebiotech.com
Total Employee:
1+
Status:
Active
Contact:
+46 704 888 555
Email Addresses:
[email protected]
Total Funding:
71.43 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Apache Wordpress Plugins IPv6
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Immune Biotech
Official Site Inspections
http://www.immunebiotech.com
- Host name: webcluster2.webpod14-cph3.one.com
- IP address: 46.30.213.177
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "Immune Biotech"
Homepage - ImmuneBiotech
ImmuneBiotech develops, markets and commercializes therapeutically effective probiotics products designed with pharmaceutical precision to manage gastrointestinal and neurological …See details»
About Us - ImmuneBiotech
ImmuneBiotech is founded on scientific innovation and curiosity with a mission to revolutionize health through the power of precision probiotics. Our organization is managed by a …See details»
Investors - ImmuneBiotech
Company profile At ImmuneBiotech, our mission is to discover, develop, and commercialize therapeutically effective probiotic products with pharmaceutical precision for the management …See details»
ImmuneBiotech AB - Crunchbase Company Profile & Funding
ImmuneBiotech AB is funded by EASME. When was the last funding round for ImmuneBiotech AB? ImmuneBiotech AB closed its last funding round on Jan 1, 2019 from a Grant round. Who …See details»
ImmuneBiotech AB - LinkedIn
ImmuneBiotech AB - a microbiome company uniquely placed to develop therapeutically effective probiotic products designed using scientific and pharmacologic methods.See details»
ImmuneBiotech 2025 Company Profile: Valuation, Funding
ImmuneBiotech General Information Description. Developer of novel therapeutics designed to target the gut microbiota and the immune system. The company focuses on therapeutic …See details»
ImmuneBiotech AB - Funding, Financials, Valuation & Investors
Jan 1, 2019 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 1, 2019: …See details»
ImmuneBiotech - VentureRadar
ImmuneBiotech AB discovers and develops novel microbiome therapeutics based on probiotic lactic acid bacteria and synbiotic formulations targeting the gut microbiota and the immune …See details»
ImmuneBiotech – SmiLe Venture Hub
ImmuneBiotech AB is an innovative microbiome research company, discovering and developing novel therapeutics based on probiotics, immunobiotics and synbiotic formulations targeting the microbiome. The company has a pre …See details»
ImmuneBiotech AB - Tech Stack, Apps, Patents & Trademarks
Jan 13, 2025 Organization. ImmuneBiotech AB . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Monthly Visits 603. Monthly Visits …See details»
ImmuneBiotech - Craft
ImmuneBiotech is a company discovering and developing probiotics for therapeutic effect based on lactic acid bacteria and symbiotic formulations. It targets gut microbiota and the immune …See details»
ImmuneBiotech Medical Sweden AB (ImmuneBiotech Medical …
了解ImmuneBiotech Medical Sweden AB (ImmuneBiotech Medical Sweden AB)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验。See details»
Immunotherapy by ImmunityBio - Cancer Vaccine Research
Apr 7, 2025 Opportunities for Trial Investigators The broad therapeutic potential and demonstrated safety of ImmunityBio’s immune-enhancing IL-15 superagonist Anktiva (N-803), …See details»
Immune Biotech - 2025 Company Profile - Tracxn
Mar 26, 2025 Immune Biotech has raised funding over 2 rounds. Its first funding round was on Apr 01, 2019. Its latest funding round was a Grant (prize money) round on Sep 30, 2019 for …See details»
ImmuneBiotech’s 10th anniversary
On the 15th of November, we celebrated ImmuneBiotech's 10th anniversary with an open house party at the Medicon Village together with friends, collaborators, customers, investors, and …See details»
ImmuneBiotech Overview | SignalHire Company Profile
Organization Website: Immunebiotechnology.com : Phone Number (11) 94263-0304: ImmuneBiotech industries Biotech: ImmuneBiotech Employees Size 1-10 employees: …See details»
SmiLe alumni company ImmuneBiotech strengthens its Board of …
Jan 31, 2024 ImmuneBiotech, a pioneering probiotic and microbiome company, is pleased to announce the appointment of life science professional Dr. Sara Malcus as Chairman of the …See details»
ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) …
Mar 13, 2025 Clinical research organization, Anova Enterprises, Inc. (Anova) is helping ImmunityBio manage the rBCG EAP. “Constrained BCG supply has improved stewardship of a …See details»
ImmuneBiotech closes fully subscribed new share issue with …
Jan 20, 2021 ImmuneBiotech will also allocate funding to finalize and disseminate data from the ongoing clinical study of GutMagnific® in ME/CFS. Furthermore, the funds will also be used to …See details»
ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) …
Mar 13, 2025 U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) ; The FDA recently authorized ImmunityBio’s …See details»